लोड हो रहा है...
Mechanisms and Management of Chimeric Antigen Receptor T-Cell Therapy Related Toxicities
Chimeric antigen receptor T-cell (CAR-T) therapy has proven to be a very effective cancer immunotherapy. Axicabtagene ciloleucel and Tisagenlecleucel are the first in class anti-CD19 CAR-T-cells currently available for relapsed-refractory adult large B-cell lymphoma. Tisagenlecleucel is also availab...
में बचाया:
| में प्रकाशित: | BioDrugs |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6733400/ https://ncbi.nlm.nih.gov/pubmed/30560413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-018-0324-z |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|